购物车
- 全部删除
- 您的购物车当前为空
SARS-CoV-2-IN-13 (compound 6) 是氯硝柳胺的类似物。在人血浆和肝S9酶测定中,SARS-CoV-2-IN-13 比氯硝柳胺更稳定。SARS-CoV-2-IN-13 口服给药时可以提高生物利用度和半衰期。SARS-CoV-2-IN-13 是SARS-CoV-2的有效抑制剂,IC50值为 0.057 μM。
为众多的药物研发团队赋能,
让新药发现更简单!
SARS-CoV-2-IN-13 (compound 6) 是氯硝柳胺的类似物。在人血浆和肝S9酶测定中,SARS-CoV-2-IN-13 比氯硝柳胺更稳定。SARS-CoV-2-IN-13 口服给药时可以提高生物利用度和半衰期。SARS-CoV-2-IN-13 是SARS-CoV-2的有效抑制剂,IC50值为 0.057 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 298 | 现货 | |
5 mg | ¥ 738 | 现货 | |
10 mg | ¥ 1,190 | 现货 | |
25 mg | ¥ 2,390 | 现货 | |
50 mg | ¥ 3,400 | 现货 | |
100 mg | ¥ 4,750 | 现货 | |
200 mg | ¥ 6,390 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 816 | 现货 |
产品描述 | SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide. SARS-CoV-2-IN-13 is more stable than niclosamide in human plasma and liver S9 enzymes assay. SARS-CoV-2-IN-13 can improve bioavailability and half-life when administered orally. SARS-CoV-2-IN-13 is a potent SARS-CoV-2 inhibitor with an IC 50 of 0.057 μM [1]. |
分子量 | 327.12 |
分子式 | C13H8Cl2N2O4 |
CAS No. | 56961-10-5 |
Smiles | Oc1ccc(Cl)cc1C(=O)Nc1ccc(c(Cl)c1)[N+]([O-])=O |
存储 | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 112.5 mg/mL (343.9 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容